- Product Details
Keywords
- Kalydeco (Ivacaftor)
- Ivacaftor
- Kalydeco
Quick Details
- ProName: Kalydeco (Ivacaftor)
- CasNo: 873054-44-5
- Molecular Formula: C24H28N2O3
- DeliveryTime: 5-7 working days
- PackAge: Discret packet for your choice
- ProductionCapacity: Metric Ton/Day
- Purity: 99%
- Transportation: EMS, DHL, FedEx, UPS, TNT
- LimitNum: 0 Metric Ton
- Impurity: 0.1%
Superiority
Ivacaftor (trade name Kalydeco, developed as VX-770) is a drug approved for patients with a certain mutation
of cystic fibrosis, which accounts for 4–5% cases of cystic fibrosis.[1][2] Ivacaftor was developed by Vertex
Pharmaceuticals in conjunction with the Cystic Fibrosis Foundation